It heats it up and inactivates part of the pathway responsible for essential tremor which is an uncontrolled ... time to respond and heal to the first treatment before doing the other side.
The partners responded to the failure by closing an open-label safety study and abandoning plans to run further SAGE-324 trials in essential tremor. At the time, Sage said it would work with ...
The companies recently announced negative results from the Phase 2 KINETIC 2 Study of investigational SAGE-324 for the chronic treatment of essential tremor (ET) and discontinued further clinical ...